We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
Dedicated to our clients' success
Services
Intellectual Property
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Meet our team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
Careers
14 August 2018
Azafaros (www.azafaros.com), a biotech company established in Leiden in the Netherlands, focusing on the development of new therapies in the field of rare metabolic disorders, announced the closing of a seed financing round. BioGeneration Ventures is the founding investor. Olivier Morand, Ph.D. and IMD alumnus, is joining Azafaros as Chief Executive Officer and member of the Board of Directors. VISCHER advised on all Swiss legal issues related to the transaction. The VISCHER team includes Christian Wyss (Partner, Corporate/M&A), Marc Prinz (Partner, Employment) and Vera Keller (Junior Associate, Corporate/M&A).
Categories: Life Sciences, Pharma, Biotech, Private Equity & Venture Capital, Startup Desk, Deals & Cases
Attorney at Law
EraCal Therapeutics AG ("EraCal"), a Swiss biotech start-up company focusing on the fight of obesity...
T3 Pharmaceuticals AG, a biotechnology company with its headquarter in Allschwil, Switzerland has...
LASCCO SA, a biomedical-technology company, and Abionic SA, a nanotechnology company, both based at...